Abstract N6-methyladenosine (m6A) is the most abundant posttranscriptional methylation
modification that occurs in mRNA and modulates the fine-tuning of various biological …

Osteoporosis is a common bone disease, characterized by a descent in bone mass due to
the dysregulation of bone homeostasis. Although different studies have identified an …

Osteoporosis is a metabolic skeletal disorder in which bone mass is depleted and bone
structure is destroyed to the degree that bone becomes fragile and prone to fractures …

Abstract N6-methyladenosine (m6A) is the most abundant epigenetic modification in
eukaryotic mRNAs and is essential for multiple RNA processing events during mammalian …

Osteoporosis is a prevalent bone disease of the aging population, which is characterized by
a decrease in bone mass because of the imbalance of bone metabolism. Although the …

Abstract N 6-methyladenosine (m 6 A), a novel epitranscriptomic RNA modification, plays
crucial roles in a variety of biological processes and diseases. Recently, there are growing …

As a systemic disease, osteoporosis (OP) results in bone density loss and fracture risk,
particularly in the hip and vertebrae. However, the underlying molecular mechanisms of OP …

Alteration of N6-methyladenosine (m6A) is closely linked to spanning biological processes
including osteoporosis (OP) development. This research focuses on the function of …

Abstract N6-methyladenosine (m 6 A) is the most prevalent modification in the eukaryotic
transcriptome and has a wide range of functions in coding and noncoding RNAs. It affects …

Abstract N 6-methyladenosine (m6A) modification is widespread in messenger RNAs and
increasing evidence suggests the crucial roles of m6A in cell differentiation and tissue …